Article
Evaluation of the Role of Tanshinone I in an In Vitro System of Charcot-Marie-Tooth Disease Type 2N.
International journal of molecular sciences - 17 Oct 2024
Zhang Jingjing, Meng Xinru, Qin Qianni, Liang Yali, Yang Guangpu, Li Shen, Li Xiaorong, Zhou Ji-Chang, Sun Litao
Abstract excerpt
Charcot-Marie-Tooth disease type 2N (CMT2N) is an inherited nerve disorder caused by mutations in the alanyl-tRNA synthetase (AlaRS) gene, resulting in muscle weakness and sensory issues. Currently, there is no cure for CMT2N. Here, we found that all five AlaRS mutations in the aminoacylation domain can interact with neuropilin-1 (Nrp1), which is consistent with our previous findings. Interestingly, three of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
